24 maj: Neonet Securities ændrer CD-ident for afvikling af handler
24 maj: Dagens ändringar 2012-05-24
24-05-2012 17:05:00

Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associate

Relateret indhold
15 okt - 
Onsdagens aktier: USA-nøgletal bankede humøret yderlige..
15 okt - 
Aktier/åbning: Vestas skyder til tops
06 okt - 
Aktier/middag: Pandora vinder terræn i faldende C20-ind..
Relateret debat
14 okt - 
112 nu! Skal vi ned i 82 igen?
13 okt - 
Jeg synes ikke den er oversolgt. En P/E på over 30. Fal..
13 okt - 
Det sagde man også om D/S Norden og den var nede i 127-..

H. Lundbeck A/S hereby reports transactions made by executives and persons and

legal entities closely associated to them with shares in H. Lundbeck A/S and

linked securities, cf. section 28a of the Danish Securities Trading Act.

The list is based on reports received by H. Lundbeck A/S from the company's

executives today or yesterday.

Name: Anders Gersel Pedersen

Job position of the Executive Vice President &

executive: Head of Research & Development

ID code (ISIN code): DK 0010287234

Description of the Share

security:

Nature of the transaction: Transferred as part of Lundbeck’s Long Term

Incentive Program for Executive Management

Date of trading: 23 May 2012

Market on which the Nasdaq OMX Copenhagen

trading was effected:

Number of traded 33,583 shares

securities:

Persons or entities under an obligation to report are defined as members of the

Executive Management and the Supervisory Board of H. Lundbeck A/S and

persons/entities closely associated to them.

Closely associated persons/entities means inter alia:

-- spouse or cohabitant

-- children below the age of 18

-- legal entities in which the insider has a controlling influence

The content of this release will have no influence on the Lundbeck Group’s

financial expectations for 2012.

Lundbeck contacts

Investors: Media:

Palle Holm Olesen Mads Kronborg

Chief Specialist, Head of Investor Relations Media Relations Manager

palo@lundbeck.com mavk@lundbeck.com

+45 36 43 24 26 +45 36 43 28 51

Magnus Thorstholm Jensen Simon Mehl Augustesen

Investor Relations Officer International Media Specialist

matj@lundbeck.com smeh@lundbeck.com

+45 36 43 38 16 +45 36 43 49 80

About Lundbeck

H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is an international pharmaceutical

company highly committed to improving the quality of life for people suffering

from brain disorders. For this purpose, Lundbeck is engaged in the research,

development, production, marketing and sale of pharmaceuticals across the

world. The company’s products are targeted at disorders such as depression and

anxiety, psychotic disorders, epilepsy and Huntington’s, Alzheimer’s and

Parkinson’s diseases.

Lundbeck was founded in 1915 by Hans Lundbeck in Copenhagen, Denmark. Today

Lundbeck employs approximately 6,000 people worldwide. Lundbeck is one of the

world’s leading pharmaceutical companies working with brain disorders. In 2011,

the company's revenue was DKK 16.0 billion (approximately EUR 2.1 billion or

USD 3.0 billion). For more information, please visit www.lundbeck.com.

Vedhæftet fil: Release no 471_1.pdf

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Eli Lilly Q3: Rammer tæt på analytikerforventningerne

23-10-2014 12:39:41
Den amerikanske medicinalvirksomhed Eli Lilly lå i tredje kvartal indtjeningsmæssigt helt op af forventningerne blandt analytikerne ifølge Bloomberg News.Det ju..

Aktier/middag: Novozymes toppper i Europa

23-10-2014 11:39:56
Efter en lidt skidt start på dagen genfandt det danske aktiemarked i løbet af torsdag formiddag de seneste dages positive momentum. Fremgangen er i høj grad dre..

Aktier/tendens: Novozymes og OW Bunker løber med overskrifterne

23-10-2014 08:29:24
Torsdag morgens regnskaber stikker i to retninger. Novozymes har opjusteret og endnu en gang præsteret pænt, mens OW Bunker formentlig står til en ny tur i skam..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas/Danske: Ser god fremtid selv uden PTC
2
Vestas: HSBC skifter holdning og anbefaler "overvægt"
3
Al-Qaeda blæser til kamp mod vestlige olietankere
4
Europa/aktier: U-vending sikrede plus på stor regnskabsdag
5
Onsdagens aktier: Bavarian blæste til vejrs på partneraftale

Relaterede aktiekurser

H Lundbeck A/S 119,70 0,5% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Relaterede selskaber
Få adgang til information og anbefalinger af relaterede selskaber med PLUS pakken.

Du får adgang til 7 værdifulde investorværktøjer til investering.

Klik her og læs mere om PLUS pakken.
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
23. oktober 2014 15:04:54
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20141015.1 - EUROWEB3 - 2014-10-23 15:04:54 - 2014-10-23 15:04:54 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x